Central to population health is active prevention of disease and its progression. How can healthcare innovations, for example in cancer screening or polygenic scores, be implemented to better prevent ill health?
Our briefings, landscape reports and evaluations, often drawn from PHG-convened workshops, can help you get to grips with the practicalities of innovating to deliver better health for all.
The NHS genomics population health service
In March 2026, PHG convened a stakeholder workshop with experts in health, research, and policy to help identify priorities and challenges in delivering the new genomics population health service. Drawing on that workshop, this report outlines actions across four key areas: testing, data and digital infrastructure, workforce, and public and patient engagement. It is designed for commissioners, public health teams, and healthcare professionals involved in developing and delivering the new service.
Unpacking polygenic scores
Polygenic scores are generating considerable debate in the biomedical and healthcare communities. Can they or can they not provide information that can be used in the prevention of common complex diseases?

Drawn from discussions with researchers, academics and health professionals, this report sets out three priorities for action arising from technological revolution in diagnosis.
The changing nature of diagnosis: implications for policy, practice and patients

PHG Foundation has been working with PROPHET.EU to build a personalised prevention roadmap for the future healthcare.

In the innovative Project DELTA we led ethical, and legal research into personalised risk prediction and AI driven pathology to detect oesophageal cancer.
Personalised health
We are unashamed champions of personalised health. And we are critical friends. Here’s what we are doing to make personalised health work for population health.


